Concourse Financial Group Securities, Inc. Cara Therapeutics, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 100 shares of CARA stock, worth $31. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$31
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$697,1620.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$527,6540.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$482,4370.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$345,0430.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$343,7680.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...